NSAV SUBSIDIARY SIGNS MAJOR AGREEMENT WITH ELI LILLY AND COMPANY
December 14 2017 - 9:31AM
InvestorsHub NewsWire
NSAV SUBSIDIARY SIGNS MAJOR AGREEMENT WITH ELI LILLY AND
COMPANY
Cresco, PA -- Net Savings Link, Inc. (OTC:
NSAV) -- InvestorsHub NewsWire -- a medical technology and
software company, announced today that its subsidiary, Shanghai
based Vital Strategic Research Institute (VSRI), has signed an
agreement with Eli Lilly and Company. Under the terms of the
agreement, VSRI will provide Eli Lilly with an assessment of Cardio
Vascular Disease (CVD) among newly diagnosed diabetes patients at
increased risk of CVD in China. China is facing the largest
diabetes epidemic in the world with around 11 percent of its
population suffering from the metabolic illness, while nearly 36
percent are pre-diabetic. CVD in China has also reached epidemic
proportions, with over 200 million Chinese suffering from the
world’s leading cause of death.
About Eli Lilly and Company
Eli Lilly and Company, a leading innovation-driven company, is
developing a growing portfolio of pharmaceutical products by
applying the latest research from its own worldwide laboratories
and from collaborations with eminent scientific organizations.
Headquartered in Indianapolis, Ind., Lilly provides answers --
through medicines and information -- for some of the world's most
urgent medical needs. Information about Lilly is available at
www.lilly.com.
NSAV subsidiary, VSRI is a medical research firm with a long
history of expertise in design, clinical trials and global
research. VSRI has collaborated with pharmaceutical giants such as
Pfizer and Bristol-Myers Squibb.
James Tilton, president of NSAV stated, “I am thrilled that we have
been able to close our first major deal since acquiring VSRI only
two months ago. It is extremely rewarding to be the CEO of a
company that is not only succeeding from a business standpoint, but
saving lives.”
NSAV's vision is the establishment of a fully integrated technology
and software company that provides turnkey technological and
software solutions to the medical industry. Over time, the Company
plans to provide a wide range of services such as software
solutions, e-commerce, advisory services, financial services,
patents and trademarks and information technology.
For further information please contact NSAV at 1 (585) 520-2102 or
investorgrowthllc@gmail.com
The NSAV corporate email address is info@nsavholdinginc.com
The NSAV corporate website can be accessed at http://nsavholdinginc.com
The NSAV Twitter account can be accessed at https://twitter.com/NSAV_MJTechCo
The NSAV Facebook account can be accessed at https://www.facebook.com/NSAVHolding
This press release contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended and Section 21E of the Securities Exchange Act of 1934,
which are intended to be covered by the safe harbors created
thereby. Investors are cautioned that, all forward-looking
statements involve risks and uncertainties, including without
limitation, the ability of Net Savings Link, Inc. to accomplish its
stated plan of business. Net Savings Link, Inc. believes that the
assumptions underlying the forward-looking statements contained
herein are reasonable, any of the assumptions could be inaccurate,
and therefore, there can be no assurance that the forward-looking
statements included in this press release will prove to be
accurate. In light of the significant uncertainties inherent in the
forward- looking statements included herein, the inclusion of such
information should not be regarded as a representation by Net
Savings Link, Inc. or any other person.
Contact
Investor Growth LLC
investorgrowthllc@gmail.com
585-520-2102
Net Savings Link (PK) (USOTC:NSAV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Net Savings Link (PK) (USOTC:NSAV)
Historical Stock Chart
From Sep 2023 to Sep 2024